• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Research & Development

How ResMed is advancing sleep and respiratory care

December 1, 2020 By Sean Whooley

The COVID-19 pandemic’s propulsion of widespread telehealth adoption has ResMed (NYSE:RMD) eyeing remote technologies for the next phase of its sleep and respiratory businesses. The president of that business for the San Diego-based company, Jim Hollingshead, told Medical Design & Outsourcing in a recent interview that the future lies with remote care and digital health offerings. “Right before the […]

Filed Under: Business/Financial News, Diagnostics, Featured, MassDevice Earnings Roundup, Patient Monitoring, Research & Development, Respiratory, Wall Street Beat Tagged With: coronavirus, COVID-19, ResMed

Boston Scientific CEO Mike Mahoney talks Lotus decision, post-COVID outlook

December 1, 2020 By Sean Whooley

Boston Scientific (NYSE:BSX) made waves this month when it recalled and retired its Lotus TAVR product line. Subsequent layoffs, first in Minnesota, then in Ireland, highlighted the impact of the decision to pull Lotus from the highly competitive market as a result of complexities related to the product delivery system and solely that — as the […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, MassDevice Earnings Roundup, Replacement Heart Valves, Research & Development, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, coronavirus, COVID-19, tavr

Who would — and wouldn’t — line up for COVID-19 vaccines?

November 24, 2020 By Nancy Crotti

Once enough people receive effective vaccines against the novel coronavirus, experts say, the end of the pandemic may be in sight. But a new poll of older adults — one of the highest-priority groups for vaccination — suggests an uphill climb lies ahead to reach that goal. In all, 58% of adults aged 50 to […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceutical, Research & Development Tagged With: AARP, BioNTech, coronavirus, COVID-19, Moderna, Pfizer, U.S. Centers for Disease Control and Prevention, UBS, University of Michigan, vaccines

BREAKING: AstraZeneca says its COVID-19 vaccine could be up to 90% effective

November 23, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) announced today that one of its COVID-19 vaccine candidate dosing regimens is 90% effective in preventing the virus. Cambridge, United Kingdom-based AstraZeneca, working in collaboration with Oxford University, found the vaccine to be highly effective in preventing COVID-19 for subjects in the UK and Brazil, with no hospitalizations or severe cases of the disease […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

MedTech 100 roundup: Industry remains strong despite slight dip

November 23, 2020 By Sean Whooley

The heights of two weeks ago may not have been reached, but the medtech industry — despite a slight dip — performed well in the stock markets once again. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.99 (Nov. 20), marking a 1% downturn […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Research & Development, Robotics, Surgical, Wall Street Beat Tagged With: becton dickinson, Boston Scientific, coronavirus, COVID-19, Johnson and Johnson, MedTech 100 Index, Medtronic, Steris Corp., tavr

Why the COVID-19 vaccine market won’t be ‘winner take all’

November 17, 2020 By Brian Buntz

There are a dozen Phase 3 COVID-19 vaccine candidates with more than 50 in either Phase 1 or Phase 2 trials. But the fact that Pfizer (NYSE:PFE) and Moderna (NSDQ:MRNA) have vaccine candidates with efficacy greater than 90% could ultimately narrow the playing field. “Efficacy matters, but I don’t think [Pfizer’s and Moderna’s efficacy rate of] greater […]

Filed Under: Biotech, Clinical Trials, Featured, Research & Development Tagged With: Clinical Trials, coronavirus, COVID-19, Moderna, Pfizer

MedTech 100 roundup: Stocks remain high after record-setting week

November 16, 2020 By Sean Whooley

Medtech stocks have been on the rise since positive news regarding COVID-19 vaccines broke last week, breaking a record in the process. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 98.99 (Nov. 13), marking a 1.4% uptick from the 97.62 points registered at the […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: 3m, Baxter, coronavirus, COVID-19, EU MDR, Joe Biden, MedTech 100 Index, Sotera Health, Stryker, Wright Medical

Joe Biden’s plan for COVID-19 and how the industry is reacting

November 9, 2020 By Sean Whooley

Following the weekend’s news that Joe Biden is now president-elect of the U.S., plenty of focus is shifting to his plan for COVID-19. While positive news regarding Pfizer and BioNTech’s vaccine candidate came through this morning, the pandemic is still roaring on, with the U.S. hitting a record 128,000 new cases on Saturday as the […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News, Medicare, Pharmaceutical, Research & Development Tagged With: AdvaMed, coronavirus, COVID-19, Joe Biden, MassMEDIC, Medical Alley Association

MedTech 100 roundup: Stocks show no signs of slowing down

November 9, 2020 By Sean Whooley

The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: BioNTech, coronavirus, COVID-19, Hologic, Inspire Medical Systems Inc., Livongo, MedTech 100 Index, Mesa Biotech, NovoCure, Oxford University, Pfizer, Stryker, Teladoc, transmedics

Report: Oxford chief says there’s ‘small chance’ COVID-19 vaccine is ready by Christmas

November 4, 2020 By Sean Whooley

The director of the group developing a COVID-19 vaccine candidate at Oxford University says it’s possible that the vaccine could be ready by Christmas. According to a Reuters report, Oxford vaccine trial chief investigator Andrew Pollard said he’s optimistic that the university, which is collaborating with AstraZeneca on the vaccine, will present trial results by the end […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

Robocath, MicroPort enter JV

November 2, 2020 By Sean Whooley

Robocath announced today that it created a joint venture with MicroPort Scientific through its MicroPort MedBot subsidiary. Rouen, France-based Robocath said in a news release that the partnership is designed to enable the commercialization of its R-One robotic-assisted platform in China, as MedBot is based in Shanghai. Both companies are set to engage in research […]

Filed Under: Business/Financial News, Funding Roundup, Research & Development, Robotics, Surgical Tagged With: MedBot, MicroPort Scientific, Robocath

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 140
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS